Lisata Therapeutics's total assets for Q3 2025 were $21.76M, a decrease of -13.52% from the previous quarter. LSTA total liabilities were $4.64M for the fiscal quarter, a 5.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.